Cargando…
Serum 25-hydroxyvitamin D and risk of type 2 diabetes in older adults: A dose–response meta-analysis of prospective cohort studies: Retraction
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794409/ https://www.ncbi.nlm.nih.gov/pubmed/29369225 http://dx.doi.org/10.1097/MD.0000000000009788 |
Ejemplares similares
-
Retraction: Serum Levels of 25-Hydroxyvitamin D and Functional Outcome among Postmenopausal Women with Hip Fracture
Publicado: (2019) -
Retracted: Discussion on the Transoral Vestibular Approach Endoscopy for TC Patients and the Significance of Serum 25-Hydroxyvitamin D Classification
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Retracted: Correlation between 25-Hydroxyvitamin D, sFlt-1, PLGF, and Hypertension in Pregnancy
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Serum 25-hydroxyvitamin D and risk of type 2 diabetes in older adults: A dose–response meta-analysis of prospective cohort studies
por: Cheng, Peng, et al.
Publicado: (2018) -
The serum 25-hydroxyvitamin D levels and hip fracture risk: a meta-analysis of prospective cohort studies
por: Lv, Qing-Bo, et al.
Publicado: (2017)